Origin Therapeutics Holdings Inc.
Save
1.41M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Origin Therapeutics Holdings Inc., an investment issuer, primarily focuses on investments in the psychedelic industry in Canada. It plans to invests in the research, design, development, testing, production, distribution, and sale of psychedelics and related activities. The company was formerly known as 1278700 B.
Similar securities
Based on sector and market capitalization
Report issue